Asia Pacific In Vitro Diagnostics (IVD) Market size to exceed $23.7bn by 2027, says Graphical Research
April 27, 2022 19:00 ET
|
Graphical Research
Pune, India, April 27, 2022 (GLOBE NEWSWIRE) -- As per a recent industry report put forward by Graphical Research, the Asia Pacific In Vitro Diagnostics (IVD) market is forecast to register its...
Precipio customer American Oncology Network (AON) selected to present HemeScreen® technology case study at Industry leading clinical laboratory conference
April 26, 2022 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., April 26, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), is excited to announce its participation and the presentation of HemeScreen,...
Provectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent Application for Use of PV-10® Immunotherapy in Hematology
April 26, 2022 07:30 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, April 26, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the United States Patent and Trademark Office (USPTO) has allowed US patent application 16/688,319,...
Provectus Biopharmaceuticals Seeks Stockholder Approval at 2022 Annual Meeting for Authority to Undertake Reverse Split of Outstanding Equities and Reduce Number of Authorized Equities by Same Ratio
April 19, 2022 16:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, April 19, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that, in conjunction with the filing of the Company’s preliminary 2022 proxy statement (Pre-14A), Provectus’...
IVD Contract Research Organization Market ($8Bn by 2028) Growth Forecast at 7.8% CAGR During 2021 to 2028 COVID Impact and Global Analysis by The Insight Partners
March 30, 2022 13:52 ET
|
The Insight Partners
New York, March 30, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “IVD Contract Research Organization Market Forecast to 2028 - COVID-19 Impact and Global Analysis...
Provectus Biopharmaceuticals Announces Synthesis of New Halogenated Xanthene Small Molecule
March 24, 2022 07:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, March 24, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company has successfully developed and manufactured a second halogenated xanthene (HX), adding to...
Veterinary Diagnostics Market Worth $9.58 billion by 2029 - Exclusive Report by Meticulous Research®
February 09, 2022 08:48 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, Feb. 09, 2022 (GLOBE NEWSWIRE) -- According to a new market research report “Veterinary Diagnostics Market by Product (Consumables {Leukemia, Influenza}, System, Software),...
Rapid Diagnostics Market Worth $18.20 Billion by 2029 — Exclusive Report by Meticulous Research®
February 01, 2022 07:00 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, Feb. 01, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled "Rapid Diagnostics Market by Product (Kits [OTC, Professional], Readers), Platform (Lateral...
Starton Therapeutics Receives Clinical Trial Authorization in Europe to Initiate Phase 1 Clinical Trial of STAR-LLD Continuous Delivery Lenalidomide
January 10, 2022 08:30 ET
|
Starton Therapeutics, Inc.
STAR-LLD is the first continuous delivery immunomodulatory drug (IMiD) in development to expand the use of lenalidomide in multiple myeloma and become the first IMiD for CLLOn track to complete...
HM43239 Demonstrates Durable Clinical Benefit in Acute Myeloid Leukemia
December 13, 2021 16:30 ET
|
Aptose Biosciences, Inc.
HM43239 Data Featured in Oral Presentation at the American Society of Hematology Annual Meeting Aptose Presents Highlights from Luxeptinib and APTO-253 and Provides Corporate Update SAN DIEGO,...